U.S. Patent
BIO 2017
National Cancer Conference
-
Latest News
Cancer Research News
- American Cancer Society Honors Dr. Abby R. Rosenberg with Prestigious Trish Greene Quality of Life Award June 27, 2022
- The American Cancer Society Highlights Impact of Dobbs v. Jackson Ruling on Cancer Patients and Their Families June 24, 2022
- New Report Shows Cancer Survivors Grew to 18 Million in the US; More Than Two-Thirds Aged 65 Years or Older June 23, 2022American Cancer Society researchers show racial disparities in cancer treatment and survival suggest large inequalities in access to care
- New Report Shows Impact of Partnership to Prevent HPV Cancers June 22, 2022
- New Perspective Shows Higher Breast Cancer Mortality for Black Women Emerged 40 Years ago June 18, 2022American Cancer Society researchers stress the need for equitable access to high-quality care
- Published on Oct 13, 2016
Robert Andtbacka, MD, CM of the Huntsman Cancer Institute, Salt Lake City, UT discusses the use of oncolytic viruses at the 2016 World Congress on Cancers of the Skin (WCCS) and the Congress of the European Association of Dermato-Oncology (EADO) in Vienna, Austria. Health Care Forum “War on Cancer” (March 30th 2017-Singapore)
-
Announcements
Related Articles
Oncolytic targeting of androgen-sensitive prostate tumor by the respiratory syncytial virus (RSV): consequences of deficient interferondependent antiviral defense - Research Article (Biomed Central)
Childhood virus RSV shows promise against adult cancer. - Science Daily
CZ BioMed licenses children’s virus turned anti-cancer agent. - San Antonio Business Journal
Category Archives: Uncategorized
Collaboration with South Korea’s Largest Hospital to Develop New Cancer Treatment
Kocal Consulting Corporation Announces Collaboration with South Korea’s Largest Hospital to Develop New Cancer Treatment Well Marker Bio Co. Ltd., a biotech division of Asan Medical Center of South Korea, signs Memorandum of Understanding with CZ Biomed Corp. and Kocal … Continue reading
Posted in Uncategorized
Leave a comment